Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Hewetson

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1983
A rapid, large scale purification procedure for gibbon interleukin 2L E Henderson, J F Hewetson, R F Hopkins, et al.
Vaccine|January 1, 1993
Protection of mice from inhaled ricin by vaccination with ricin or by passive treatment with heterologous antibodyJ F Hewetson, V R Rivera, D A Creasia, et al.
International Journal of Cancer|July 15, 1973
Immunological studies on a case of recurrent Burkitt's lymphoma during immune stimulant treatmentP Gunvén, G Klein, W Henle, et al.
Archives of Virology|January 1, 1980
Infection of rhesus monkeys and chimpanzees with Epstein-Barr virusP H Levine, S A Leiseca, J F Hewetson, et al.
International Journal of Cancer|April 15, 1982
Sera from patients with undifferentiated nasopharyngeal carcinoma contain a factor which abrogates specific Epstein-Barr virus antigen-induced lymphocyte responseS K Sundar, D V Ablashi, L S Kamaraju, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1983
A rapid, large scale purification procedure for gibbon interleukin 2L E Henderson, J F Hewetson, R F Hopkins, et al.
Vaccine|January 1, 1993
Protection of mice from inhaled ricin by vaccination with ricin or by passive treatment with heterologous antibodyJ F Hewetson, V R Rivera, D A Creasia, et al.
International Journal of Cancer|July 15, 1973
Immunological studies on a case of recurrent Burkitt's lymphoma during immune stimulant treatmentP Gunvén, G Klein, W Henle, et al.
Archives of Virology|January 1, 1980
Infection of rhesus monkeys and chimpanzees with Epstein-Barr virusP H Levine, S A Leiseca, J F Hewetson, et al.
International Journal of Cancer|April 15, 1982
Sera from patients with undifferentiated nasopharyngeal carcinoma contain a factor which abrogates specific Epstein-Barr virus antigen-induced lymphocyte responseS K Sundar, D V Ablashi, L S Kamaraju, et al.
Pageof 4